HPC
ELGX

HM Payson & Co’s Endologix Inc ELGX Stock Holding History

HM Payson & Co’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-150
Closed -$1K – 996
2019
Q3 		$1K Hold
150
– – ﹤0.01% 936
2019
Q2 		$1K Buy
+150
New +$1.02K ﹤0.01% 946

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

HM Payson & Co's ELGX Position: Q4 2019 in Review

HM Payson & Co sold out of Endologix Inc (ELGX) in Q4 2019, closing a stake of 150 shares — an estimated $1K sold.

HM Payson & Co first reported a position in ELGX in Q2 2019 and held it in 2 quarters. The position peaked at $1K in Q3 2019. 57 funds tracked by Wall St. Rank hold ELGX as of Q4 2019.

  • HM Payson & Co reported no remaining Endologix Inc position as of Q4 2019 after selling out during the quarter.
  • HM Payson & Co sold 150 Endologix Inc shares in Q4 2019, an estimated $1K.
  • HM Payson & Co first reported a position in Endologix Inc in Q2 2019 and held it in 2 quarters.
  • HM Payson & Co's Endologix Inc position peaked at $1K in Q3 2019.
  • 57 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2019.

Based on HM Payson & Co's 13F filing for Q4 2019, filed 18 Feb 2020.